by Talking Medicines | Aug 10, 2022
Changing market Consumers are changing. Their expectations are higher, and it is becoming ever more difficult for brands to stand out amongst the noise of competitors. With 80% of consumers now saying they would be more likely to make a purchase from a brand...
by Talking Medicines | Mar 3, 2021
Pharma Business International spoke with Jo Halliday, CEO of Talking Medicines, the world’s first social intelligence company designed specifically for the pharmaceutical industry. The full article can be found here on page 10-11 Tell us about Talking Medicines?...
by Talking Medicines | Jan 22, 2021
In December Talking Medicines carried out two ‘pulse’ surveys of the UK public to gauge opinion towards COVID-19 vaccines and found that over the month, attitude had softened, with more people intending to take the vaccine once it becomes available to them. The...
by Talking Medicines | Jan 5, 2021
COO Elizabeth Fairley was recently interviewed by publisher Drug Discovery World on whether the pharmaceutical industry is ready to listen directly to patients? Elizabeth commented that “There has been a growing realisation that pharmaceutical companies must...
by Talking Medicines | Nov 4, 2020
Talking Medicines, the world’s first social intelligence company for the pharmaceutical industry, has received a significant boost with a £1.1 million funding deal to scale up its AI-based data technology platform for measuring patient sentiment. Tern Plc, the...
